TEVA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Teva Pharmaceutical Industries Ltd

Watchlist Manager

Watchlist

Price: 34.43 USD 4.87% Market Closed

Market Cap: $39B

	Teva Pharmaceutical Industries Ltd NYSE:TEVA	IL
	Ebusco Holding NV AEX:EBUS	NL
	Cbrain A/S CSE:CBRAIN	DK
H	Highland Copper Company Inc OTC:HDRSF	CA
	Acuren Corp NYSE:TIC	US

Profitability Summary

Teva Pharmaceutical Industries Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

53%

Strong 3Y Average Gross Margin

51%

Gross Margin is Increasing

49% > 53%

Healthy Operating Margin

24%

Sustainable 3Y Average Operating Margin

23%

Operating Margin is Increasing

20% > 24%

Low Net Margin

Negative 3Y Average Net Margin

-3%

Net Margin is Increasing

-11% > 9%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

6% > 7%

Positive ROE

22%

Negative 3Y Average ROE

Positive 3Y Average ROIC

17%

ROIC is Increasing

5% > 14%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.